Medicine shortage communication (MSC): Insulin lispro Sanofi (insulin lispro 100 units/ml solution for injection in cartridge and pre-filled pen)

Insulin lispro Sanofi

Human medicines European public assessment report (EPAR): Neulasta, pegfilgrastim, Date of authorisation: 22/08/2002, Revision: 41, Status: Authorised

Human medicines European public assessment report (EPAR): Zubsolv, buprenorphine,naloxone, Date of authorisation: 10/11/2017, Revision: 14, Status: Authorised

Human medicines European public assessment report (EPAR): Symkevi, tezacaftor,ivacaftor, Date of authorisation: 31/10/2018, Revision: 17, Status: Authorised

Programme - Joint HMA/EMA multi-stakeholder workshop on Patient Registries December 2025

Medicinal products for human use: monthly figures - November 2025

Human medicines European public assessment report (EPAR): Xermelo, telotristat ethyl, Date of authorisation: 17/09/2017, Revision: 18, Status: Authorised

Human medicines European public assessment report (EPAR): Scemblix, asciminib, Date of authorisation: 25/08/2022, Revision: 13, Status: Authorised

Agenda - HMA/EMA Annual Data Forum 2025